Filed: 11/8/2022ACC: 0001104659-22-115835
📋 What this filing means
SOFINNOVA INVESTMENTS, INC. filed this quarterly 13F‑HR report disclosing 55 equity positions with a total reported market value of $1.72M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
55
Positions
$1.72M
Total AUM (reported)
70.58M
Total Shares
Allocation by class
COM$1.36M79.4%
SPONSORED ADR$144.0K8.4%
CL A$88.4K5.1%
UNIT SER 1$40.1K2.3%
SBI HEALTHCARE$36.3K2.1%
RUSSELL 2000 ETF$33.0K1.9%
SHS$5.3K0.3%
Portfolio Concentration
Top 3$801.8K46.7%
4–10$384.5K22.4%
11–25$341.0K19.8%
Rest$191.4K11.1%
Top 3 weight
46.7%
Top 10 weight
69.0%
Voting Authority Distribution
Total shares with voting rights: 70.58M
Sole
Full voting authority
70.58M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole55
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings55
Rows:
Karuna Therapeutics Inc
SOLEShares2.07M
TypeSH
Market value$466.3K
27.13%
Sole
2.07M
Shared
0.00
None
0.00
Cincor Pharma Inc
SOLEShares6.08M
TypeSH
Market value$199.5K
11.61%
Sole
6.08M
Shared
0.00
None
0.00
Natera Inc
SOLEShares3.10M
TypeSH
Market value$136.0K
7.91%
Sole
3.10M
Shared
0.00
None
0.00
Merck & Co Inc
SOLEShares883.47K
TypeSH
Market value$76.1K
4.43%
Sole
883.47K
Shared
0.00
None
0.00
Vera Therapeutics Inc
SOLEShares3.18M
TypeSH
Market value$67.8K
3.94%
Sole
3.18M
Shared
0.00
None
0.00
Aerovate Therapeutics Inc
SOLEShares3.76M
TypeSH
Market value$62.3K
3.63%
Sole
3.76M
Shared
0.00
None
0.00
Ascendis Pharma A/S
SOLEShares499.82K
TypeSH
Market value$51.6K
3.00%
Sole
499.82K
Shared
0.00
None
0.00
Sanofi SA
SOLEShares1.26M
TypeSH
Market value$48.1K
2.80%
Sole
1.26M
Shared
0.00
None
0.00
Invesco QQQ Trust Series 1
SOLEShares150K
TypeSH
Market value$40.1K
2.33%
Sole
150K
Shared
0.00
None
0.00
AstraZeneca PLC
SOLEShares701.88K
TypeSH
Market value$38.5K
2.24%
Sole
701.88K
Shared
0.00
None
0.00
Health Care Select Sector SPDR
SOLEShares300K
TypeSH
Market value$36.3K
2.11%
Sole
300K
Shared
0.00
None
0.00
iShares Russell 2000 ETF
SOLEShares200K
TypeSH
Market value$33.0K
1.92%
Sole
200K
Shared
0.00
None
0.00
Y-mAbs Therapeutics Inc
SOLEShares2.19M
TypeSH
Market value$31.6K
1.84%
Sole
2.19M
Shared
0.00
None
0.00
United Therapeutics Corp
SOLEShares147.56K
TypeSH
Market value$30.9K
1.80%
Sole
147.56K
Shared
0.00
None
0.00
Gilead Sciences Inc
SOLEShares482.40K
TypeSH
Market value$29.8K
1.73%
Sole
482.40K
Shared
0.00
None
0.00
Biomarin Pharmaceutical Inc
SOLEShares294.75K
TypeSH
Market value$25.0K
1.45%
Sole
294.75K
Shared
0.00
None
0.00
CTI Biopharma Corp
SOLEShares3.61M
TypeSH
Market value$21.0K
1.22%
Sole
3.61M
Shared
0.00
None
0.00
Reata Pharmaceuticals Inc
SOLEShares818.38K
TypeSH
Market value$20.6K
1.20%
Sole
818.38K
Shared
0.00
None
0.00
Intuitive Surgical Inc
SOLEShares96.30K
TypeSH
Market value$18.1K
1.05%
Sole
96.30K
Shared
0.00
None
0.00
iRhythm Technologies Inc
SOLEShares140.09K
TypeSH
Market value$17.6K
1.02%
Sole
140.09K
Shared
0.00
None
0.00
Dexcom Inc
SOLEShares205.95K
TypeSH
Market value$16.6K
0.97%
Sole
205.95K
Shared
0.00
None
0.00
Sarepta Therapeutics Inc
SOLEShares141.44K
TypeSH
Market value$15.6K
0.91%
Sole
141.44K
Shared
0.00
None
0.00
Cytokinetics Inc
SOLEShares320.72K
TypeSH
Market value$15.5K
0.90%
Sole
320.72K
Shared
0.00
None
0.00
Iveric Bio Inc
SOLEShares820.66K
TypeSH
Market value$14.7K
0.86%
Sole
820.66K
Shared
0.00
None
0.00
Lilly Eli & Co
SOLEShares45.50K
TypeSH
Market value$14.7K
0.86%
Sole
45.50K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Karuna Therapeutics IncSOLE | COM | 2.07M | SH | $466.3K 27.13% | 2.07M | 0.00 | 0.00 |
Cincor Pharma IncSOLE | COM | 6.08M | SH | $199.5K 11.61% | 6.08M | 0.00 | 0.00 |
Natera IncSOLE | COM | 3.10M | SH | $136.0K 7.91% | 3.10M | 0.00 | 0.00 |
Merck & Co IncSOLE | COM | 883.47K | SH | $76.1K 4.43% | 883.47K | 0.00 | 0.00 |
Vera Therapeutics IncSOLE | CL A | 3.18M | SH | $67.8K 3.94% | 3.18M | 0.00 | 0.00 |
Aerovate Therapeutics IncSOLE | COM | 3.76M | SH | $62.3K 3.63% | 3.76M | 0.00 | 0.00 |
Ascendis Pharma A/SSOLE | SPONSORED ADR | 499.82K | SH | $51.6K 3.00% | 499.82K | 0.00 | 0.00 |
Sanofi SASOLE | SPONSORED ADR | 1.26M | SH | $48.1K 2.80% | 1.26M | 0.00 | 0.00 |
Invesco QQQ Trust Series 1SOLE | UNIT SER 1 | 150K | SH | $40.1K 2.33% | 150K | 0.00 | 0.00 |
AstraZeneca PLCSOLE | SPONSORED ADR | 701.88K | SH | $38.5K 2.24% | 701.88K | 0.00 | 0.00 |
Health Care Select Sector SPDRSOLE | SBI HEALTHCARE | 300K | SH | $36.3K 2.11% | 300K | 0.00 | 0.00 |
iShares Russell 2000 ETFSOLE | RUSSELL 2000 ETF | 200K | SH | $33.0K 1.92% | 200K | 0.00 | 0.00 |
Y-mAbs Therapeutics IncSOLE | COM | 2.19M | SH | $31.6K 1.84% | 2.19M | 0.00 | 0.00 |
United Therapeutics CorpSOLE | COM | 147.56K | SH | $30.9K 1.80% | 147.56K | 0.00 | 0.00 |
Gilead Sciences IncSOLE | COM | 482.40K | SH | $29.8K 1.73% | 482.40K | 0.00 | 0.00 |
Biomarin Pharmaceutical IncSOLE | COM | 294.75K | SH | $25.0K 1.45% | 294.75K | 0.00 | 0.00 |
CTI Biopharma CorpSOLE | COM | 3.61M | SH | $21.0K 1.22% | 3.61M | 0.00 | 0.00 |
Reata Pharmaceuticals IncSOLE | CL A | 818.38K | SH | $20.6K 1.20% | 818.38K | 0.00 | 0.00 |
Intuitive Surgical IncSOLE | COM | 96.30K | SH | $18.1K 1.05% | 96.30K | 0.00 | 0.00 |
iRhythm Technologies IncSOLE | COM | 140.09K | SH | $17.6K 1.02% | 140.09K | 0.00 | 0.00 |
Dexcom IncSOLE | COM | 205.95K | SH | $16.6K 0.97% | 205.95K | 0.00 | 0.00 |
Sarepta Therapeutics IncSOLE | COM | 141.44K | SH | $15.6K 0.91% | 141.44K | 0.00 | 0.00 |
Cytokinetics IncSOLE | COM | 320.72K | SH | $15.5K 0.90% | 320.72K | 0.00 | 0.00 |
Iveric Bio IncSOLE | COM | 820.66K | SH | $14.7K 0.86% | 820.66K | 0.00 | 0.00 |
Lilly Eli & CoSOLE | COM | 45.50K | SH | $14.7K 0.86% | 45.50K | 0.00 | 0.00 |
Page 1 of 3